Urology · Ponce, PR
NPI
1720063332
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
609 Ave Tito Castro, Ste. 102, Pmb 363
Ponce, PR, 00716
Phone (787) 284-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
618 services
Medicare patients, 2024
123
Average age 75
Drug cost, 2024
$3.0M
8,244 prescriptions
Company payments, 2025
$2,390
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gilberto Ruiz Deya was code 99213 (office e&m - established), 189 times for 117 patients. In total Gilberto Ruiz Deya billed 618 services in 34 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 189 | 117 | $57.04 | $11K |
| 51741 Test - Miscellaneous | Office | 13 | 12 | $7.35 | $95.56 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 12 | 11 | $68.36 | $820 |
By year: 2022 $37K for 942 services; 2023 $35K for 446 services; 2024 $34K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gilberto Ruiz Deya prescribed most often to Medicare patients was Tamsulosin Hcl, with 2,439 prescriptions and refills. In total Gilberto Ruiz Deya wrote 8,244 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 2,439 | 3,561 | 675 | $24K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 1,126 | 1,560 | 311 | $87K |
| Finasteride Generic | 697 | 908 | 172 | $7,190 |
| Ciprofloxacin Hcl Generic | 583 | 583 | 497 | $4,261 |
| Diclofenac Sodium Generic | 364 | 364 | 320 | $2,706 |
| Cephalexin Generic | 339 | 339 | 321 | $2,696 |
| Sildenafil Citrate Generic | 294 | 294 | 83 | $4,336 |
| Myrbetriq Mirabegron | 288 | 336 | 72 | $154K |
| Estradiol Generic | 189 | 566 | 106 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 180 | 180 | 166 | $972 |
| Potassium Citrate Er Potassium Citrate | 157 | 203 | 45 | $10K |
| Ketoconazole Generic | 152 | 156 | 86 | $3,492 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 144 | 202 | 40 | $1,825 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 143 | 143 | 107 | $2,850 |
| Xtandi Enzalutamide | 128 | 128 | 14 | $1.8M |
Brand drugs: - claims; generic drugs: 7,587 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gilberto Ruiz Deya $2,390 ($2,390 in general payments such as food, travel and fees) from 12 companies. The largest payer was Merck Sharp & Dohme LLC with $1,728.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 8 | $1,728 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $200 |
| Ferring Pharmaceuticals Inc. | 1 | $113 |
| Medtronic, Inc. MDT | 3 | $82.55 |
| Pbg Puerto Rico LLC | 3 | $67.68 |
| Tolmar, Inc. | 3 | $52.24 |
| Bayer Puerto Rico Inc. BAYN.DE | 2 | $37.07 |
| Boston Scientific Corporation BSX | 1 | $29.42 |
| Becton, Dickinson and Company BDX | 1 | $24.59 |
| Novo Nordisk Inc NVO | 1 | $23.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.